On the contrary, M2 KCs decrease the progression of MASLD by inducing M1 KCs apoptosis and releasing transforming growth factor (TGF)-β1 and IL-13 which can promote liver remodeling and tissue repair (38, 39). This evidence concerns the gene TBCE and metabolic dysfunction-associated steatotic liver disease.